# Verification of Predictive Biomarkers for Pancreatic Cancer Treatment Using Multicenter Liquid Biopsy

> **NCT04241367** · — · COMPLETED · sponsor: **National Cancer Center, Korea** · enrollment: 420 (actual)

## Conditions studied

- Pancreas Adenocarcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04241367
- **Lead sponsor:** National Cancer Center, Korea
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-28
- **Primary completion:** 2021-06-03
- **Final completion:** 2025-12-31
- **Target enrollment:** 420 (ACTUAL)
- **Last updated:** 2026-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04241367

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04241367, "Verification of Predictive Biomarkers for Pancreatic Cancer Treatment Using Multicenter Liquid Biopsy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04241367. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*